Parris RJ, Webb DJ: The endothelin system in cardiovascular physiology and pathophysiology . Vasc Med2:431-434, 1997.
4.
Clozel M., Breu V., Burri K., et al: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature336:759-761, 1993.
5.
Goldie RG: Endothelins in health and disease. Clin Exp Pharmacol Physiol26:145-148, 1999.
6.
Weber C., Gasser R., Hopfgartner G.: Absorption, excretion and metabolism of the endothelin receptor antagonist bosentan in healthy male subjects. Drug Metab Dispos27:810-815, 1999.
7.
Haynes WG, Webb DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone . Lancet344:852-854, 1994.
8.
Guarda E., Katwa LC, Myers PR, et al: Effects of endothelins on collagen turnover in cardiac fibroblasts . Cardiovasc Res27:2130-2134,1993.
9.
Morbidelli L. , Orlando C., Maggi CA, et al: Proliferation and migration of endothelial cells is promoted by endothelins via activation of ETB receptors. Am J Physiol269:H686-H695, 1995.
10.
Bek EL, McMillen MAEndothelins are angiogenic. J Cardiovasc Pharmacol36:S136-S139, 2000.
11.
Salani D., Taraboletti G., Rosano L., et al: Endothelin-1 induces an angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Am J Pathol157:1703-1711, 2000.
12.
Haber E., Lee M-E.: Endothelin to the rescue?Nature370:252-253, 1994.
13.
Kurihara Y. , Kurihara H., Suzuki H., et al: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1 . Nature368:703-710, 1994.
14.
Hosoda K., Hammer RE, Richardson JA, et al: Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice . Cell79:1267-1276, 1994 .
15.
Spence S., Anderson C., Cukierski M., et al: Teratogenic effects of the endothelin receptor antagonist L-753,037 in the rat. Reprod Toxicol13:15-29, 1999.
16.
Shichiri M. , Kato H., Marumo F., et al: Endothelin-1 as an autocrine/paracrine apoptosis survival factor for endothelial cells. Hypertension30:1198-1203, 1997.
Davies MJ, Richardson PD, Woolf N., et al: Risk of thrombosis in human atherosclerotic plaques: Role of extracellular lipid, macrophage and smooth muscle cell content. Br Heart J69:377-381, 1993.
21.
Jones GT, vanRij AM, Solomon C., et al: Endothelin-1 is increased overlying atherosclerotic plaques in human arteries. Atheroscler124:25-35, 1996.
22.
Trachtenberg JD, Sun S., Choi ET, et al: Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Pharmacol22:S355-S359, 1993.
23.
Dashwood MR , Noertersheuser P., Kirchengast M., et al: Altered endothelin-1 binding following balloon angioplasty of pig coronary arteries: Effect of the ETA receptor antagonist, LU 135252. Cardiovasc Res43:445-456, 1999.
24.
Dashwood MR , Mehta D., Izzat MB, et al: Distribution of endothelin-1 (ET) receptors (ETA and ETB) and immunoreactive ET-1 in porcine saphenous vein-carotid artery interposition grafts. Atheroscler137:233-242, 1998.
25.
Streissguth AP, Clarren SK, Jones KL: Natural history of the fetal alcohol syndrome: A 10-year follow-up of eleven patients. Lancet13:85-91, 1985.
26.
Tsui Jcs, Baker DM, Dowd G., et al: A potential role of endothelin-1 in increased microvessel growth in skeletal muscle of patients with critical limb ischaemia. J Physiol (London) 536:112-113P, 2001.
27.
Shao R., Yan W., Rockey DC: Regulation of endothelin-1 synthesis by endothelin-converting enzyme during wound healing. J Biol Chem274:3228-3234, 1999.
28.
Shi-Wen X., Denton CP, Dashwood MR, et al: Fibroblast matrix gene expression and connective tissue remodelling: Role of endothelin-1. J Invest Dermatol116:417-425, 2001.
29.
Hocher B., Thone-Reineke C., Bauer C., et al: The paracrine endothelin system: Pathophysiology and implications in clinical medicine. EurJ Clin Chem Clin Biochem35:175-189, 1997.
30.
De-Melo Jd , Tonussi CR, D'Orleans-Juste P., et al: Articular nociception induced by endothelin-1, carrageenan and LPS in naive and previously inflamed knee-joints in the rat: Inhibition by endothelin receptor antagonists. Pain77:261-269, 1998.
31.
Jarvis MF, Wessale JL, Zhu CZ, et al: ABT-627, an endothelin ET(A) receptor-selective antagonist, attenuates tactile alloynia in a diabetic rat model of neuropathic pain. Eur J Pharmacol388:29-35, 2000.
32.
Cameron NE, Dines KC, Cotter MA: The potential contribution of endothelin-1 to neurovascular abnormalities in streptazotocin-diabetic rats. Diabetologia37:1209-1215, 1994.
33.
Shichiri M. , Hirata Y., Nakajima T., et al: Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J Clin Invest87:1867-1871, 1991.